<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Virtual Journal Club &#187; Ann Saudi Med</title>
	<atom:link href="http://beckerinfo.net/JClub/category/ann-saudi-med/feed/" rel="self" type="application/rss+xml" />
	<link>http://beckerinfo.net/JClub</link>
	<description>Division of Hospital Medicine Virtual Journal Club</description>
	<lastBuildDate>Wed, 08 Feb 2012 10:30:59 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Home intravenous antibiotics in a tertiary care hospital in Saudi Arabia.</title>
		<link>http://beckerinfo.net/JClub/2012/01/19/home-intravenous-antibiotics-in-a-tertiary-care-hospital-in-saudi-arabia/</link>
		<comments>http://beckerinfo.net/JClub/2012/01/19/home-intravenous-antibiotics-in-a-tertiary-care-hospital-in-saudi-arabia/#comments</comments>
		<pubDate>Thu, 19 Jan 2012 21:03:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ann Saudi Med]]></category>

		<guid isPermaLink="false">http://beckerinfo.net/JClub/?guid=14fdfc4aab3d47e5a1d2f0cf1f4f71dc</guid>
		<description><![CDATA[Home intravenous antibiotics in a tertiary care hospital in Saudi Arabia.
        Ann Sa...]]></description>
			<content:encoded><![CDATA[<body><table><tr><td><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21911981/?tool=pubmed" /> </td></tr></table><p><b>Home intravenous antibiotics in a tertiary care hospital in Saudi Arabia.</b></p>
        <p>Ann Saudi Med. 2011 Sep-Oct;31(5):457-61</p>
        <p>Authors:  Baharoon S, Almodaimeg H, Al Watban H, Al Jahdali H, Alenazi T, Al Sayyari A, Al Dawood A, Al-Sultan M, Al Safi E</p>
        <p>Abstract<br/>
        BACKGROUND AND OBJECTIVE: Home intravenous (IV) antibiotic programs are becoming increasingly popular worldwide because of their efficacy and safety. However, in Saudi Arabia these programs have not yet become an integrated part of the health care system. We present our experience with a home IV antibiotic program, as one of the major health care providers in Saudi Arabia.<br/>
        DESIGN AND SETTING: Retrospective chart review of patients enrolled in the King Abdulaziz Medical City Home Health Care IV Antibiotic Program from 1 May 2005 (the start of the program) until 30 December 2007.<br/>
        METHODS: In addition to demographic characteristics, we collected data on the site of infection, the clinical diagnosis, the isolated microorganisms, and the type of antibiotics given. Outcome measures evaluated included the relapse rate, failure rate, the safety of the program, and readmission rates.<br/>
        RESULTS: Of the 155 patients enrolled, 152 patients completed the program. Those who completed the program had a mean (SD) age of 52.8 (23.9) years. The mean (SD) duration of the IV antibiotic treatment was 20.6 (17) days. Three patients refused to complete the intended duration of therapy. Peripherally inserted central catheter (PICC) lines were utilized in 130 patients (86%). One-hundred and thirty-one patients completed the intended duration of therapy, although the therapy was changed from the initial plan for 21 (13.8%) patients. Readmission to the hospital during therapy was required for 13 patients (8.5%). Osteomyelitis was the most frequently encountered diagnosis (65 patients, 42.8%), followed by urinary tract infection (36 patients, 23.7%).<br/>
        CONCLUSIONS: The home health care-based IV antibiotic program was an effective and safe alternative for in-patient management of patients with non-life-threatening infections, and was associated with a very low complication rate. Home IV antibiotic programs should be used more frequently as part of the health care system in Saudi Arabia.<br/></p><p>PMID: 21911981 [PubMed - indexed for MEDLINE]</p></body>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2012/01/19/home-intravenous-antibiotics-in-a-tertiary-care-hospital-in-saudi-arabia/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Management of ascites due to gastrointestinal malignancy.</title>
		<link>http://beckerinfo.net/JClub/2009/11/18/management-of-ascites-due-to-gastrointestinal-malignancy/</link>
		<comments>http://beckerinfo.net/JClub/2009/11/18/management-of-ascites-due-to-gastrointestinal-malignancy/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 23:15:41 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ann Saudi Med]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="http://www.saudiannals.net/article.asp?issn=0256-4947;year=2009;volume=29;issue=5;spage=369;epage=377;aulast=Saif"><img src="http://www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--www.saudiannals.net-images-linkout.gif" border="0"></a> </td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&#38;cmd=Display&#38;dopt=PubMed_PubMed&#38;from_uid=19700895">Related Articles</a></td></tr></table>
        <p><b>Management of ascites due to gastrointestinal malignancy.</b></p>
        <p>Ann Saudi Med. 2009 Sep-Oct;29(5):369-77</p>
        <p>Authors:  Saif MW, Siddiqui IA, Sohail MA</p>
        <p>Ascites is the pathological accumulation of fluid within the abdominal cavity. The most common cancers associated with ascites are adenocarcinomas of the ovary, breast, colon, stomach and pancreas. Symptoms include abdominal distension, nausea, vomiting, early satiety, dyspnea, lower extremity edema, weight gain and reduced mobility. There are many potential causes of ascites in cancer patients, including peritoneal carcinomatosis, malignant obstruction of draining lymphatics, portal vein thrombosis, elevated portal venous pressure from cirrhosis, congestive heart failure, constrictive pericarditis, nephrotic syndrome and peritoneal infections. Depending on the clinical presentation and expected survival, a diagnostic evaluation is usually indicated as it will impact both prognosis and the treatment approach. Key tests include serum albumin and protein and a simultaneous diagnostic paracentesis, checking ascitic fluid, WBCs, albumin, protein and cytology. Median survival after diagnosis of malignant ascites is in the range of 1 to 4 months; survival is apt to be longer for ovarian and breast cancers if systemic anti-cancer treatments are available.</p>
        <p>PMID: 19700895 [PubMed - indexed for MEDLINE]</p>]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="http://www.saudiannals.net/article.asp?issn=0256-4947;year=2009;volume=29;issue=5;spage=369;epage=377;aulast=Saif"><img src="http://www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--www.saudiannals.net-images-linkout.gif" border="0"></a> </td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Display&amp;dopt=PubMed_PubMed&amp;from_uid=19700895">Related Articles</a></td></tr></table>
        <p><b>Management of ascites due to gastrointestinal malignancy.</b></p>
        <p>Ann Saudi Med. 2009 Sep-Oct;29(5):369-77</p>
        <p>Authors:  Saif MW, Siddiqui IA, Sohail MA</p>
        <p>Ascites is the pathological accumulation of fluid within the abdominal cavity. The most common cancers associated with ascites are adenocarcinomas of the ovary, breast, colon, stomach and pancreas. Symptoms include abdominal distension, nausea, vomiting, early satiety, dyspnea, lower extremity edema, weight gain and reduced mobility. There are many potential causes of ascites in cancer patients, including peritoneal carcinomatosis, malignant obstruction of draining lymphatics, portal vein thrombosis, elevated portal venous pressure from cirrhosis, congestive heart failure, constrictive pericarditis, nephrotic syndrome and peritoneal infections. Depending on the clinical presentation and expected survival, a diagnostic evaluation is usually indicated as it will impact both prognosis and the treatment approach. Key tests include serum albumin and protein and a simultaneous diagnostic paracentesis, checking ascitic fluid, WBCs, albumin, protein and cytology. Median survival after diagnosis of malignant ascites is in the range of 1 to 4 months; survival is apt to be longer for ovarian and breast cancers if systemic anti-cancer treatments are available.</p>
        <p>PMID: 19700895 [PubMed - indexed for MEDLINE]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2009/11/18/management-of-ascites-due-to-gastrointestinal-malignancy/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Electrical cardioversion.</title>
		<link>http://beckerinfo.net/JClub/2009/09/02/electrical-cardioversion/</link>
		<comments>http://beckerinfo.net/JClub/2009/09/02/electrical-cardioversion/#comments</comments>
		<pubDate>Wed, 02 Sep 2009 20:28:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ann Saudi Med]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="http://www.saudiannals.net/article.asp?issn=0256-4947;year=2009;volume=29;issue=3;spage=201;epage=206;aulast=Sucu"><img src="http://www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--www.saudiannals.net-images-linkout.gif" border="0"></a> </td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&#38;cmd=Display&#38;dopt=PubMed_PubMed&#38;from_uid=19448376">Related Articles</a></td></tr></table>
        <p><b>Electrical cardioversion.</b></p>
        <p>Ann Saudi Med. 2009 May-Jun;29(3):201-6</p>
        <p>Authors:  Sucu M, Davutoglu V, Ozer O</p>
        <p>External electrical cardioversion was first performed in the 1950s. Urgent or elective cardioversions have specific advantages, such as termination of atrial and ventricular tachycardia and recovery of sinus rhythm. Electrical cardioversion is life-saving when applied in urgent circumstances. The succcess rate is increased by accurate tachycardia diagnosis, careful patient selection, adequate electrode (paddles) application, determination of the optimal energy and anesthesia levels, prevention of embolic events and arrythmia recurrence and airway conservation while minimizing possible complications. Potential complications include ventricular fibrillation due to general anesthesia or lack of synchronization between the direct current (DC) shock and the QRS complex, thromboembolus due to insufficient anticoagulant therapy, non-sustained VT, atrial arrhythmia, heart block, bradycardia, transient left bundle branch block, myocardial necrosis, myocardial dysfunction, transient hypotension, pulmonary edema and skin burn. Electrical cardioversion performed in patients with a pacemaker or an incompatible cardioverter defibrillator may lead to dysfunction, namely acute or chronic changes in the pacing or sensitivity threshold. Although this procedure appears fairly simple, serious consequences might occur if inappropriately perfformed.</p>
        <p>PMID: 19448376 [PubMed - indexed for MEDLINE]</p>]]></description>
			<content:encoded><![CDATA[<table border="0" width="100%"><tr><td align="left"><a href="http://www.saudiannals.net/article.asp?issn=0256-4947;year=2009;volume=29;issue=3;spage=201;epage=206;aulast=Sucu"><img src="http://www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--www.saudiannals.net-images-linkout.gif" border="0"></a> </td><td align="right"><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Display&amp;dopt=PubMed_PubMed&amp;from_uid=19448376">Related Articles</a></td></tr></table>
        <p><b>Electrical cardioversion.</b></p>
        <p>Ann Saudi Med. 2009 May-Jun;29(3):201-6</p>
        <p>Authors:  Sucu M, Davutoglu V, Ozer O</p>
        <p>External electrical cardioversion was first performed in the 1950s. Urgent or elective cardioversions have specific advantages, such as termination of atrial and ventricular tachycardia and recovery of sinus rhythm. Electrical cardioversion is life-saving when applied in urgent circumstances. The succcess rate is increased by accurate tachycardia diagnosis, careful patient selection, adequate electrode (paddles) application, determination of the optimal energy and anesthesia levels, prevention of embolic events and arrythmia recurrence and airway conservation while minimizing possible complications. Potential complications include ventricular fibrillation due to general anesthesia or lack of synchronization between the direct current (DC) shock and the QRS complex, thromboembolus due to insufficient anticoagulant therapy, non-sustained VT, atrial arrhythmia, heart block, bradycardia, transient left bundle branch block, myocardial necrosis, myocardial dysfunction, transient hypotension, pulmonary edema and skin burn. Electrical cardioversion performed in patients with a pacemaker or an incompatible cardioverter defibrillator may lead to dysfunction, namely acute or chronic changes in the pacing or sensitivity threshold. Although this procedure appears fairly simple, serious consequences might occur if inappropriately perfformed.</p>
        <p>PMID: 19448376 [PubMed - indexed for MEDLINE]</p>]]></content:encoded>
			<wfw:commentRss>http://beckerinfo.net/JClub/2009/09/02/electrical-cardioversion/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

